{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:30:56Z","timestamp":1791390656029,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.breast.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T12:47:15Z","timestamp":1673268435000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Omission of axillary sentinel lymph node biopsy in early invasive breast cancer"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3014-370X","authenticated-orcid":false,"given":"Toralf","family":"Reimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2023.01.002_bib1","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.breast.2023.01.002_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2023.01.002_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs Observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.01.002_bib4","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1200\/JCO.21.00934","article-title":"Management of the axilla in early stage breast cancer: Ontario health (cancer care Ontario) and ASCO guideline","volume":"39","author":"Brackstone","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib6","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1055\/a-1904-6231","article-title":"AGO recommendations for the surgical therapy of breast cancer: update 2022","volume":"82","author":"Banys-Paluchowski","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.breast.2023.01.002_bib9","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.breast.2021.11.018","article-title":"De-escalating axillary surgery in early-stage breast cancer","volume":"62","author":"Hersh","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.01.002_bib10","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1002\/cncr.33960","article-title":"Omission of sentinel node biopsy for breast cancer: historical context and future perspectives on a modern controversy","volume":"127","author":"Jatoi","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2023.01.002_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000491703","article-title":"Is axillary sentinel lymph node biopsy required in patients who undergo primary breast surgery?","volume":"13","author":"Reimer","year":"2018","journal-title":"Breast Care"},{"key":"10.1016\/j.breast.2023.01.002_bib12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jamaoncol.2015.2337","article-title":"Staging the axilla in early breast cancer: will imaging replace surgery?","volume":"1","author":"Gentilini","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. Results from the SOUND (Sentinel node vs. Observation after axillary Ultra-souND) trial","volume":"42","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0042-122853","article-title":"Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c\/iT1-2) in the context of breast conserving therapy: first results following commencement of the Intergroup-Sentinel-Mamma (INSEMA) trial","volume":"77","author":"Reimer","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.breast.2023.01.002_bib15","article-title":"Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","volume":"55","author":"Reimer","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.breast.2023.01.002_bib16","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1200\/JCO.2014.56.5838","article-title":"Radiation field design in the ACOSOG Z0011 (Alliance) trial","volume":"32","author":"Jagsi","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ijrobp.2020.04.042","article-title":"Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial","volume":"107","author":"Hildebrandt","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.breast.2023.01.002_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"Van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2023.01.002_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4048\/jbc.2021.24.e47","article-title":"Imaging protocol and criteria for evaluation of axillary lymph nodes in the NAUTILUS trial","volume":"24","author":"Chang","year":"2021","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.breast.2023.01.002_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-022-09273-1","article-title":"No axillary surgical treatment for lymph node-negative patients after ultra-sonography (NAUTILUS): protocol of a prospective randomized clinical trial","volume":"22","author":"Jung","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2023.01.002_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-022-06804-w","article-title":"Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey","author":"Banys-Paluchowski","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.breast.2023.01.002_bib24","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.19.02576","article-title":"Locoregional management after neoadjuvant chemotherapy","volume":"38","author":"Morrow","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamasurg.2017.0562","article-title":"Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery","volume":"152","author":"Tadros","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2023.01.002_bib26","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1016\/j.ejca.2012.05.023","article-title":"Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy","volume":"48","author":"Houssami","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2023.01.002_bib27","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/bjs.12026","article-title":"Toward omitting sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with clinically node-negative breast cancer","volume":"108","author":"Van der Noordaa","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2023.01.002_bib28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamasurg.2018.2696","article-title":"Association of low nodal positivity rate among patients with erbB2-positive or triple-negative breast cancer and breast pathologic complete response to neoadjuvant chemotherapy","volume":"153","author":"Barron","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2023.01.002_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/SLA.0000000000003126","article-title":"Correlation between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy","volume":"271","author":"Samiei","year":"2020","journal-title":"Ann Surg"},{"issue":"22","key":"10.1016\/j.breast.2023.01.002_bib30","first-page":"613","article-title":"Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial","volume":"2045","author":"Kuerer","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2023.01.002_bib31","doi-asserted-by":"crossref","first-page":"E3698","DOI":"10.3390\/cancers12123698","article-title":"Avoiding axillary sentinel lymph node biopsy after neoadjuvant systemic therapy in breast cancer: rationale for the prospective, multicentric EUBREAST-01 trial","volume":"12","author":"Reimer","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.breast.2023.01.002_bib32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.breast.2005.05.009","article-title":"Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection","volume":"15","author":"Engel","year":"2006","journal-title":"Breast"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:46:31Z","timestamp":1760777191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":28,"alternative-id":["S0960977623000024"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.01.002","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omission of axillary sentinel lymph node biopsy in early invasive breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}